December 11th, 2020 - December 18th, 2021
This conference has already taken place.
Description
New innovations in cancer treatment are improving cancer survival. However, some of these new treatments have new or unexpected cardiovascular toxicities. Many cancer survivors are now living longer, and as they do, they experience the potential cardiotoxic effects of these treatments.
This symposium is now available. To access this symposium, you must register to access the Cardio-Oncology Symposium Channel. In addition, you will be able to participate in a live Zoom webinar on Friday, December 18 at 3:30 p.m. (EST).
EXPERT PANEL
December 18, 2020, 3:30pm – 5pm
A recording of this panel will be available after December 18. If not already registered, be sure to register to use the link below to access this panel.
See the Educational Resources from Commercial Exhibitors Post Panel Zoom Rooms document below for links to vendors.
Dates and Times
Start: 12/11/2020 12:00 AM
End: 12/18/2021 12:00 AM
Objectives
At the conclusion of this activity, participants should be able to:
1. Describe short-term and delayed onset cardiotoxic effects of emerging cancer therapies.
2. Recognize appropriate identification strategies when cardiovascular disease problems may be developing with your cancer patient
3. Practical strategies for screening and monitoring for cardiovascular disease among patients receiving cancer treatment
4. Compare cardiac imaging modalities and results to determine best test for specific cancer patients
5. Discuss the role of cardio-protective therapy in on your cancer patient population
6. Identify and integrate current cardio-oncology guidelines into practice
7. Review specific case scenarios (i.e. suspected immune checkpoint myocarditis, ibrutinib, TKIs, and radiation)
8. Recognize advancements and challenges in treating amyloidosis.
Pricing
| Tier | Price |
|---|---|
| Physicians | $0.00 |
| Nurses/Nurse Practitioners | $0.00 |
| Pharmacists/Pharmacy Techs | $0.00 |
| Allied Health Professionals | $0.00 |
Conference Files
| File | Link |
|---|---|
|
Cardio-Oncology Agenda The Cardio-Oncology Agenda is a listing of the topics presented in each of the three session modules, as well as details on the speakers. |
Download |
|
Educational Resources from Commercial Exhibitors A Participants may use this platform to view educational information on commercial products or contact company representatives for additional information. |
Download |
|
Educational Resources from Commercial Exhibitors B Participants may use this platform to view educational information on commercial products or contact company representatives for additional information |
Download |
Speakers
Location
Columbus, OH
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.